| Literature DB >> 17850061 |
Iain M McDonald1, Carol Austin, Ildiko M Buck, David J Dunstone, John Gaffen, Eric Griffin, Elaine A Harper, Robert A D Hull, S Barret Kalindjian, Ian D Linney, Caroline M R Low, Dipa Patel, Michael J Pether, Michelle Raynor, Sonia P Roberts, Mark E Shaxted, John Spencer, Katherine I M Steel, David A Sykes, Paul T Wright, Wei Xun.
Abstract
A 1,3,4-benzotriazepine was identified as a suitable lead in our effort toward obtaining a non-peptide parathyroid hormone-1 receptor (PTH1R) antagonist. A process of optimization afforded derivatives displaying nanomolar PTH1R affinity, a representative example of which behaved as a PTH1R antagonist in cell-based cyclic adenosine monophosphate (cAMP) assays, with selectivity over PTH2 receptors.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17850061 DOI： 10.1021/jm0707626
Source DB: PubMed Journal: J Med Chem ISSN： 0022-2623 Impact factor: 7.446